Public Profile

OptiNose US, Inc.

OptiNose US, Inc., a leading player in the biopharmaceutical industry, is headquartered in the United States and focuses on innovative solutions for patients with chronic sinusitis and other nasal conditions. Founded in 2010, the company has made significant strides in developing unique delivery systems that enhance the efficacy of medications, particularly through its proprietary intranasal technology. OptiNose's core products, including the XHANCE® nasal spray, stand out for their ability to deliver medication directly to the nasal passages, improving patient outcomes and adherence. With a commitment to advancing nasal drug delivery, OptiNose has established a strong market position, recognised for its contributions to the treatment of chronic rhinosinusitis. The company continues to expand its operational reach, aiming to transform the landscape of nasal therapeutics.

DitchCarbon Score

How does OptiNose US, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

OptiNose US, Inc.'s score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

OptiNose US, Inc.'s reported carbon emissions

OptiNose US, Inc. currently does not have publicly available carbon emissions data for the most recent year, nor are there specific reduction targets or climate pledges outlined in their initiatives. Without concrete emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. However, the absence of data may indicate a need for further transparency in their environmental strategies. As the industry increasingly prioritises climate action, it is essential for companies like OptiNose to establish clear emissions reporting and reduction goals to align with global sustainability standards.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. OptiNose US, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for OptiNose US, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

OptiNose US, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Novartis

CH
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Boehringer Ingelheim Pharmaceuticals, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Astra Zeneca

GB
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Chiesi Farmaceutici

IT
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Boehringer Ingelheim International GmbH

DE
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Merck Sharp & Dohme LLC

US
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers